Understanding Quality and Costs in Congenital Heart Surgery
了解先天性心脏病手术的质量和成本
基本信息
- 批准号:8670376
- 负责人:
- 金额:$ 63.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAreaBayesian MethodBenchmarkingBirthCardiac Surgery proceduresCaringCase MixesChildChildhoodClinicalCollaborationsCongenital AbnormalityCongenital Heart DefectsCost SavingsDataData SetDatabasesEnvironmentFeedbackFundingFutureGoalsHealthcare SystemsHeartHospitalizationHospitalized ChildHospitalsIncentivesIndividualKnowledgeLesionLinkMeasuresMethodologyMetricMorbidity - disease rateNational Heart, Lung, and Blood InstituteNoiseOperative Surgical ProceduresOutcomeParticipantPatientsPediatric HospitalsPerformancePoliciesPolicy MakerPopulationProcessProcess MeasureProxyQuality ControlQuality IndicatorQuality of CareRegistriesReportingResearchResourcesRisk AdjustmentScheduleSeverity of illnessSocietiesStructureSurvivorsTechniquesTestingThoracic SurgeonVariantabstractingadministrative databasebasecongenital heart disordercostdata registrydesignexperienceimprovedinnovationmortalitypublic health relevanceresponsesuccess
项目摘要
DESCRIPTION (provided by applicant): Understanding Quality and Costs in Congenital Heart Surgery Abstract Congenital heart defects are the most common birth defects, and children requiring heart surgery account for the highest resource utilization across US children's hospitals. While overall outcomes have improved in recent years, wide variation across hospitals remains, and numerous stakeholders aim to improve quality of care for these patients. These efforts include federal initiatives such as the pediatric sections of the Affordable Care Act
scheduled to take effect over the next several years, which will tie reimbursements to children's hospitals to achieving not only high quality but also cost savings. The success of these initiatives is dependent on both reliable measures of quality and an understanding of the relationship between quality and costs, particularly for common and resource-intense conditions such as congenital heart disease. Unfortunately, existing quality indicators in this population and
flawed, with limited ability to reliably discriminate between hospitals. Composite measures, which empirically combine information across multiple relevant quality domains, have been shown to be more reliable indicators of quality across a variety of subspecialties, but have not been developed to date in congenital heart surgery. In addition, existing quality metrics and alternatives have not been evaluated against measures of resource utilization, which has become increasingly important in the current environment. This project aims to address these knowledge gaps through applying advanced Bayesian methods to empirically combine information across multiple quality domains to develop a composite quality metric in congenital heart surgery. The measure will be validated through testing its ability to discriminate between hospitals, and forecast future performance, in comparison to existing individual metrics. Second, we will examine the relationship between our composite measure of quality and cost, and investigate the types of costs most associated with poor quality. To conduct these analyses, we will leverage an innovative collaboration between two major stakeholders in the field, and link the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database (a rich clinical registry) with the Children's Hospital Association (CHA) Database (a large all-payer administrative database containing important resource utilization information), which will create a unique dataset encompassing nearly all US pediatric heart centers. Our results will have immediate value to policy makers and payers currently designing incentives aimed at improving quality and reducing costs across children's hospitals. In addition, the information generated from this project will be available for immediate inclusion in the regular feedback reports to US children's hospitals participating in STS and CHA (nearly all US pediatric heart centers), which will allow hospitals to better measure and benchmark their performance against national data and target areas for improvement.
摘要先天性心脏缺陷是最常见的出生缺陷,需要心脏手术的儿童在美国儿童医院的资源利用率最高。虽然近年来总体结果有所改善,但各医院之间的差异仍然很大,许多利益相关者的目标是提高对这些患者的护理质量。这些努力包括联邦倡议,如《平价医疗法案》的儿科部分
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara Pasquali其他文献
Sara Pasquali的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara Pasquali', 18)}}的其他基金
Understanding Quality and Costs in Congenital Heart Surgery
了解先天性心脏病手术的质量和成本
- 批准号:
9458788 - 财政年份:2014
- 资助金额:
$ 63.08万 - 项目类别:
Understanding Quality and Costs in Congenital Heart Surgery
了解先天性心脏病手术的质量和成本
- 批准号:
8829332 - 财政年份:2014
- 资助金额:
$ 63.08万 - 项目类别:
Understanding Quality and Costs in Congenital Heart Surgery
了解先天性心脏病手术的质量和成本
- 批准号:
9233181 - 财政年份:2014
- 资助金额:
$ 63.08万 - 项目类别:
Career Development in Outcomes Assessment in Congenital Heart Surgery
先天性心脏病手术结果评估的职业发展
- 批准号:
8589152 - 财政年份:2010
- 资助金额:
$ 63.08万 - 项目类别:
Career Development in Outcomes Assessment in Congenital Heart Surgery
先天性心脏病手术结果评估的职业发展
- 批准号:
7950371 - 财政年份:2010
- 资助金额:
$ 63.08万 - 项目类别:
Career Development in Outcomes Assessment in Congenital Heart Surgery
先天性心脏病手术结果评估的职业发展
- 批准号:
8113935 - 财政年份:2010
- 资助金额:
$ 63.08万 - 项目类别:
Career Development in Outcomes Assessment in Congenital Heart Surgery
先天性心脏病手术结果评估的职业发展
- 批准号:
8464215 - 财政年份:2010
- 资助金额:
$ 63.08万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.08万 - 项目类别:
Research Grant